MRI phenotypes of the brain are related to future stroke and mortality in patients with manifest arterial disease: The SMART-MR study

    Research output: Contribution to journalArticleAcademicpeer-review

    22 Downloads (Pure)

    Abstract

    Neurodegenerative and neurovascular diseases lead to heterogeneous brain abnormalities. A combined analysis of these abnormalities by phenotypes of the brain might give a more accurate representation of the underlying aetiology. We aimed to identify different MRI phenotypes of the brain and assessed the risk of future stroke and mortality within these subgroups. In 1003 patients (59 ± 10 years) from the Second Manifestations of ARTerial disease-Magnetic Resonance (SMART-MR) study, different quantitative 1.5T brain MRI markers were used in a hierarchical clustering analysis to identify 11 distinct subgroups with a different distribution in brain MRI markers and cardiovascular risk factors, and a different risk of stroke (Cox regression: from no increased risk compared to the reference group with relatively few brain abnormalities to HR = 10.34; 95% CI 3.80↔28.12 for the multi-burden subgroup) and mortality (from no increased risk compared to the reference group to HR = 4.00; 95% CI 2.50↔6.40 for the multi-burden subgroup). In conclusion, within a group of patients with manifest arterial disease, we showed that different MRI phenotypes of the brain can be identified and that these were associated with different risks of future stroke and mortality. These MRI phenotypes can possibly classify individual patients and assess their risk of future stroke and mortality.

    Original languageEnglish
    JournalJournal of Cerebral Blood Flow and Metabolism
    DOIs
    Publication statusE-pub ahead of print/First online - 14 Dec 2018

    Keywords

    • Atherosclerosis
    • Brain imaging
    • Cluster analysis
    • Magnetic resonance imaging
    • Patient outcomes

    Fingerprint Dive into the research topics of 'MRI phenotypes of the brain are related to future stroke and mortality in patients with manifest arterial disease: The SMART-MR study'. Together they form a unique fingerprint.

  • Cite this